- Home
- MYPS vs ENTA Comparison
MYPS vs ENTA Comparison
Compare MYPS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYPS
- ENTA
- Stock Information
- Founded
- MYPS 2011
- ENTA 1995
- Country
- MYPS United States
- ENTA United States
- Employees
- MYPS N/A
- ENTA N/A
- Industry
- MYPS EDP Services
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- MYPS Technology
- ENTA Health Care
- Exchange
- MYPS Nasdaq
- ENTA Nasdaq
- Market Cap
- MYPS 192.0M
- ENTA 255.1M
- IPO Year
- MYPS N/A
- ENTA 2013
- Fundamental
- Price
- MYPS $1.60
- ENTA $12.19
- Analyst Decision
- MYPS Buy
- ENTA Hold
- Analyst Count
- MYPS 4
- ENTA 5
- Target Price
- MYPS $3.33
- ENTA $19.00
- AVG Volume (30 Days)
- MYPS 171.8K
- ENTA 128.8K
- Earning Date
- MYPS 10-31-2024
- ENTA 08-05-2024
- Dividend Yield
- MYPS N/A
- ENTA N/A
- EPS Growth
- MYPS N/A
- ENTA N/A
- EPS
- MYPS N/A
- ENTA N/A
- Revenue
- MYPS $303,388,000.00
- ENTA $71,960,000.00
- Revenue This Year
- MYPS N/A
- ENTA N/A
- Revenue Next Year
- MYPS $3.21
- ENTA $5.14
- P/E Ratio
- MYPS N/A
- ENTA N/A
- Revenue Growth
- MYPS N/A
- ENTA N/A
- 52 Week Low
- MYPS $1.43
- ENTA $8.08
- 52 Week High
- MYPS $3.43
- ENTA $17.80
- Technical
- Relative Strength Index (RSI)
- MYPS 48.93
- ENTA 44.33
- Support Level
- MYPS $1.43
- ENTA $11.46
- Resistance Level
- MYPS $1.58
- ENTA $12.14
- Average True Range (ATR)
- MYPS 0.07
- ENTA 0.53
- MACD
- MYPS 0.03
- ENTA -0.01
- Stochastic Oscillator
- MYPS 73.91
- ENTA 37.06
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore, and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.